Hematology, Transfusion and Cell Therapy (HEMO) 2020

Results Of The PEGASUS Phase 3 Randomized Trial Demonstrating Superiority Of The C3 Inhibitor, Pegcetacoplan, Compared To Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Access Resources

Real-World Ravulizumab Dosing Patterns Among Patients With Paroxysmal Nocturnal Hemoglobinuria In A US Population

Access Resources